Consistent with these findings, our study showed that irisin augments AMPK activation in neuroblastoma cells and SH-SY5Y cells treated with PrP106–126, and that UCP2 knockdown eliminates this AMPK activation. Here, FNDC5 is linked to neuroblastoma.